A histopathological study of the effects of 6-month versus 12-month interferon α-2b therapy in chronic hepatitis C
- 31 December 1996
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 25 (6) , 833-841
- https://doi.org/10.1016/s0168-8278(96)80286-8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- L'hépatite CLa Revue de Médecine Interne, 1994
- Histological outcome in patients with chronic hepatitis C given a 60‐week interferon alfa‐2b treatment courseLiver International, 1994
- Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients With Chronic Hepatitis CHepatology, 1994
- Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitisGastroenterology, 1994
- Randomised trial of lymphoblastoid α-interferon in chronic hepatitis C: Effects on inflammation, fibrogenesis and viremiaJournal of Hepatology, 1993
- Post treatment histologic outcome in patients with chronic hepatitis C treated with recombinant alpha interferonHepatology, 1993
- Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver DiseaseNew England Journal of Medicine, 1993
- Results of long term interferon treatment in non A non B/C chronic active hepatitis. The French Group for the study of NANB/C chronic hepatitis treatment.Gut, 1993
- Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitisGastroenterology, 1991
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981